Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 219

1.

Standard biobanking conditions prevent evaporation of body fluid samples.

Willemse EA, Koel-Simmelink MJ, Durieux-Lu S, van der Flier WM, Teunissen CE.

Clin Chim Acta. 2015 Mar 10;442:141-5. doi: 10.1016/j.cca.2015.01.036. Epub 2015 Feb 4.

PMID:
25661086
[PubMed - in process]
2.

The influence of genetic variants in SORL1 gene on the manifestation of Alzheimer's disease.

Louwersheimer E, Ramirez A, Cruchaga C, Becker T, Kornhuber J, Peters O, Heilmann S, Wiltfang J, Jessen F, Visser PJ, Scheltens P, Pijnenburg YA, Teunissen CE, Barkhof F, van Swieten JC, Holstege H, Van der Flier WM; Alzheimer's Disease Neuroimaging Initiative and Dementia Competence Network.

Neurobiol Aging. 2014 Dec 11. pii: S0197-4580(14)00804-5. doi: 10.1016/j.neurobiolaging.2014.12.007. [Epub ahead of print]

PMID:
25659857
[PubMed - as supplied by publisher]
3.

Standardized evaluation of algorithms for computer-aided diagnosis of dementia based on structural MRI: The CADDementia challenge.

Bron EE, Smits M, van der Flier WM, Vrenken H, Barkhof F, Scheltens P, Papma JM, Steketee RM, Méndez Orellana C, Meijboom R, Pinto M, Meireles JR, Garrett C, Bastos-Leite AJ, Abdulkadir A, Ronneberger O, Amoroso N, Bellotti R, Cárdenas-Peña D, Álvarez-Meza AM, Dolph CV, Iftekharuddin KM, Eskildsen SF, Coupé P, Fonov VS, Franke K, Gaser C, Ledig C, Guerrero R, Tong T, Gray KR, Moradi E, Tohka J, Routier A, Durrleman S, Sarica A, Di Fatta G, Sensi F, Chincarini A, Smith GM, Stoyanov ZV, Sørensen L, Nielsen M, Tangaro S, Inglese P, Wachinger C, Reuter M, van Swieten JC, Niessen WJ, Klein S; for the Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2015 Jan 31. pii: S1053-8119(15)00073-7. doi: 10.1016/j.neuroimage.2015.01.048. [Epub ahead of print]

PMID:
25652394
[PubMed - as supplied by publisher]
4.

Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics.

Prestia A, Caroli A, Wade SK, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen CE, Wall A, Carter SF, Schöll M, Choo IH, Nordberg A, Scheltens P, Frisoni GB.

Alzheimers Dement. 2015 Jan 31. pii: S1552-5260(14)02890-8. doi: 10.1016/j.jalz.2014.12.001. [Epub ahead of print]

PMID:
25646957
[PubMed - as supplied by publisher]
5.

Mild cognitive impairment with suspected nonamyloid pathology (SNAP): Prediction of progression.

Caroli A, Prestia A, Galluzzi S, Ferrari C, van der Flier WM, Ossenkoppele R, Van Berckel B, Barkhof F, Teunissen C, Wall AE, Carter SF, Schöll M, Choo IH, Grimmer T, Redolfi A, Nordberg A, Scheltens P, Drzezga A, Frisoni GB; Alzheimer's Disease Neuroimaging Initiative; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2015 Feb 3;84(5):508-15. doi: 10.1212/WNL.0000000000001209. Epub 2015 Jan 7.

PMID:
25568301
[PubMed - in process]
6.

The Dutch Parelsnoer Institute - Neurodegenerative diseases; methods, design and baseline results.

Aalten P, Ramakers I, Biessels G, de Deyn P, Koek HL, OldeRikkert M, Oleksik AM, Richard E, Smits LL, van Swieten JC, Teune LK, van der Lugt A, Barkhof F, Teunissen CE, Rozendaal N, Verhey F, van der Flier WM.

BMC Neurol. 2014 Dec 31;14(1):1060. [Epub ahead of print]

PMID:
25551191
[PubMed - as supplied by publisher]
Free PMC Article
7.

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease.

Kvartsberg H, Duits FH, Ingelsson M, Andreasen N, Öhrfelt A, Andersson K, Brinkmalm G, Lannfelt L, Minthon L, Hansson O, Andreasson U, Teunissen CE, Scheltens P, Van der Flier WM, Zetterberg H, Portelius E, Blennow K.

Alzheimers Dement. 2014 Dec 19. pii: S1552-5260(14)02863-5. doi: 10.1016/j.jalz.2014.10.009. [Epub ahead of print]

PMID:
25533203
[PubMed - as supplied by publisher]
8.

Cortical phase changes measured using 7-T MRI in subjects with subjective cognitive impairment, and their association with cognitive function.

van Rooden S, Buijs M, van Vliet ME, Versluis MJ, Webb AG, Oleksik AM, van de Wiel L, Middelkoop HA, Blauw GJ, Weverling-Rynsburger AW, Goos JD, van der Flier WM, Koene T, Scheltens P, Barkhof F, van de Rest O, Slagboom PE, van Buchem MA, van der Grond J.

NMR Biomed. 2014 Dec 19. doi: 10.1002/nbm.3248. [Epub ahead of print]

PMID:
25522735
[PubMed - as supplied by publisher]
9.

Serum Leptin is not Altered nor Related to Cognitive Decline in Alzheimer's Disease.

Teunissen CE, van der Flier WM, Scheltens P, Duits A, Wijnstok N, Nijpels G, Dekker JM, Blankenstein RM, Heijboer AC.

J Alzheimers Dis. 2015 Jan 1;44(3):809-13. doi: 10.3233/JAD-141503.

PMID:
25352450
[PubMed - in process]
10.

More atrophy of deep gray matter structures in frontotemporal dementia compared to Alzheimer's disease.

Möller C, Dieleman N, van der Flier WM, Versteeg A, Pijnenburg Y, Scheltens P, Barkhof F, Vrenken H.

J Alzheimers Dis. 2015 Jan 1;44(2):635-47. doi: 10.3233/JAD-141230.

PMID:
25322925
[PubMed - in process]
11.

Trajectories of cognitive decline in different types of dementia.

Smits LL, van Harten AC, Pijnenburg YA, Koedam EL, Bouwman FH, Sistermans N, Reuling IE, Prins ND, Lemstra AW, Scheltens P, van der Flier WM.

Psychol Med. 2014 Sep 17:1-9. [Epub ahead of print]

PMID:
25229325
[PubMed - as supplied by publisher]
12.

The heart-brain connection: a multidisciplinary approach targeting a missing link in the pathophysiology of vascular cognitive impairment.

van Buchem MA, Biessels GJ, Brunner la Rocca HP, de Craen AJ, van der Flier WM, Ikram MA, Kappelle LJ, Koudstaal PJ, Mooijaart SP, Niessen W, van Oostenbrugge R, de Roos A, van Rossum AC, Daemen MJ.

J Alzheimers Dis. 2014;42 Suppl 4:S443-51. doi: 10.3233/JAD-141542.

PMID:
25213769
[PubMed - in process]
13.

Angiotensin-converting enzyme in cerebrospinal fluid and risk of brain atrophy.

Jochemsen HM, van der Flier WM, Ashby EL, Teunissen CE, Jones RE, Wattjes MP, Scheltens P, Geerlings MI, Kehoe PG, Muller M.

J Alzheimers Dis. 2015 Jan 1;44(1):153-62. doi: 10.3233/JAD-131496.

PMID:
25201786
[PubMed - in process]
14.

Diagnostic impact of CSF biomarkers for Alzheimer's disease in a tertiary memory clinic.

Duits FH, Prins ND, Lemstra AW, Pijnenburg YA, Bouwman FH, Teunissen CE, Scheltens P, van der Flier WM.

Alzheimers Dement. 2014 Aug 21. pii: S1552-5260(14)02461-3. doi: 10.1016/j.jalz.2014.05.1753. [Epub ahead of print]

PMID:
25156643
[PubMed - as supplied by publisher]
15.

7T T₂*-weighted magnetic resonance imaging reveals cortical phase differences between early- and late-onset Alzheimer's disease.

van Rooden S, Doan NT, Versluis MJ, Goos JD, Webb AG, Oleksik AM, van der Flier WM, Scheltens P, Barkhof F, Weverling-Rynsburger AW, Blauw GJ, Reiber JH, van Buchem MA, Milles J, van der Grond J.

Neurobiol Aging. 2015 Jan;36(1):20-6. doi: 10.1016/j.neurobiolaging.2014.07.006. Epub 2014 Jul 15.

PMID:
25113794
[PubMed - in process]
16.

Mutation frequency of PRKAR1B and the major familial dementia genes in a Dutch early onset dementia cohort.

Cohn-Hokke PE, Wong TH, Rizzu P, Breedveld G, van der Flier WM, Scheltens P, Baas F, Heutink P, Meijers-Heijboer EJ, van Swieten JC, Pijnenburg YA.

J Neurol. 2014 Nov;261(11):2085-92. doi: 10.1007/s00415-014-7456-y. Epub 2014 Aug 10.

PMID:
25108559
[PubMed - in process]
17.

Widespread disruption of functional brain organization in early-onset Alzheimer's disease.

Adriaanse SM, Binnewijzend MA, Ossenkoppele R, Tijms BM, van der Flier WM, Koene T, Smits LL, Wink AM, Scheltens P, van Berckel BN, Barkhof F.

PLoS One. 2014 Jul 31;9(7):e102995. doi: 10.1371/journal.pone.0102995. eCollection 2014.

PMID:
25080229
[PubMed - in process]
Free PMC Article
18.

SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease.

Ramirez A, van der Flier WM, Herold C, Ramonet D, Heilmann S, Lewczuk P, Popp J, Lacour A, Drichel D, Louwersheimer E, Kummer MP, Cruchaga C, Hoffmann P, Teunissen C, Holstege H, Kornhuber J, Peters O, Naj AC, Chouraki V, Bellenguez C, Gerrish A; International Genomics of Alzheimer's Project (IGAP); Alzheimer's Disease Neuroimaging Initiative (ADNI), Heun R, Frölich L, Hüll M, Buscemi L, Herms S, Kölsch H, Scheltens P, Breteler MM, Rüther E, Wiltfang J, Goate A, Jessen F, Maier W, Heneka MT, Becker T, Nöthen MM.

Hum Mol Genet. 2014 Dec 15;23(24):6644-58. doi: 10.1093/hmg/ddu372. Epub 2014 Jul 15.

PMID:
25027320
[PubMed - in process]
19.

Altered distribution of the EphA4 kinase in hippocampal brain tissue of patients with Alzheimer's disease correlates with pathology.

Rosenberger AF, Rozemuller AJ, van der Flier WM, Scheltens P, van der Vies SM, Hoozemans JJ.

Acta Neuropathol Commun. 2014 Jul 16;2:79. doi: 10.1186/s40478-014-0079-9.

PMID:
25027113
[PubMed - in process]
Free PMC Article
20.

Brain volume and white matter hyperintensities as determinants of cerebral blood flow in Alzheimer's disease.

Benedictus MR, Binnewijzend MA, Kuijer JP, Steenwijk MD, Versteeg A, Vrenken H, Scheltens P, Barkhof F, van der Flier WM, Prins ND.

Neurobiol Aging. 2014 Dec;35(12):2665-70. doi: 10.1016/j.neurobiolaging.2014.06.001. Epub 2014 Jun 13.

PMID:
25018106
[PubMed - in process]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk